Free Trial

Sivik Global Healthcare LLC Decreases Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

UnitedHealth Group logo with Medical background

Sivik Global Healthcare LLC reduced its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 60.0% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 5,000 shares of the healthcare conglomerate's stock after selling 7,500 shares during the period. UnitedHealth Group accounts for approximately 1.4% of Sivik Global Healthcare LLC's portfolio, making the stock its 29th largest position. Sivik Global Healthcare LLC's holdings in UnitedHealth Group were worth $2,619,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also bought and sold shares of the company. NewSquare Capital LLC purchased a new position in shares of UnitedHealth Group during the fourth quarter valued at approximately $25,000. Marshall & Sterling Wealth Advisors Inc. purchased a new stake in UnitedHealth Group during the 4th quarter valued at about $26,000. Hurley Capital LLC purchased a new stake in shares of UnitedHealth Group during the fourth quarter valued at approximately $28,000. Aster Capital Management DIFC Ltd bought a new position in UnitedHealth Group in the 4th quarter valued at approximately $30,000. Finally, Promus Capital LLC bought a new position in shares of UnitedHealth Group during the fourth quarter valued at $32,000. Institutional investors own 87.86% of the company's stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently issued reports on the company. Wall Street Zen downgraded UnitedHealth Group from a "buy" rating to a "hold" rating in a research note on Saturday, May 24th. Piper Sandler reduced their price objective on UnitedHealth Group from $552.00 to $353.00 and set an "overweight" rating for the company in a research note on Tuesday, June 3rd. Baird R W lowered shares of UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a report on Wednesday, June 11th. Wolfe Research decreased their price objective on shares of UnitedHealth Group from $501.00 to $390.00 and set an "outperform" rating on the stock in a research report on Tuesday, May 20th. Finally, Hsbc Global Res cut UnitedHealth Group from a "hold" rating to a "moderate sell" rating in a report on Wednesday, May 21st. One analyst has rated the stock with a sell rating, nine have assigned a hold rating and sixteen have assigned a buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $427.09.

View Our Latest Stock Report on UnitedHealth Group

Insider Activity

In related news, Director Timothy Patrick Flynn acquired 1,533 shares of the firm's stock in a transaction dated Wednesday, May 14th. The shares were purchased at an average cost of $320.80 per share, for a total transaction of $491,786.40. Following the acquisition, the director now owns 6,033 shares in the company, valued at $1,935,386.40. The trade was a 34.07% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Kristen Gil purchased 3,700 shares of the business's stock in a transaction on Thursday, May 15th. The shares were acquired at an average price of $271.17 per share, for a total transaction of $1,003,329.00. Following the completion of the purchase, the director now directly owns 3,818 shares of the company's stock, valued at approximately $1,035,327.06. This trade represents a 3,135.59% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have acquired 109,408 shares of company stock worth $31,607,768 in the last quarter. Corporate insiders own 0.28% of the company's stock.

UnitedHealth Group Stock Up 1.6%

NYSE UNH traded up $4.91 during trading on Tuesday, hitting $305.59. The company's stock had a trading volume of 8,755,449 shares, compared to its average volume of 7,381,079. The business's 50 day simple moving average is $353.44 and its 200-day simple moving average is $460.22. The company has a market cap of $277.21 billion, a PE ratio of 12.80, a P/E/G ratio of 1.41 and a beta of 0.44. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.85 and a quick ratio of 0.85. UnitedHealth Group Incorporated has a fifty-two week low of $248.88 and a fifty-two week high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing the consensus estimate of $7.29 by ($0.09). The business had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. UnitedHealth Group had a return on equity of 26.29% and a net margin of 5.39%. During the same quarter last year, the company posted $6.91 EPS. On average, equities analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 24th. Shareholders of record on Monday, June 16th will be issued a $2.21 dividend. This is a boost from UnitedHealth Group's previous quarterly dividend of $2.10. The ex-dividend date is Monday, June 16th. This represents a $8.84 dividend on an annualized basis and a yield of 2.89%. UnitedHealth Group's payout ratio is presently 37.02%.

UnitedHealth Group Company Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Featured Articles

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Should You Invest $1,000 in UnitedHealth Group Right Now?

Before you consider UnitedHealth Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.

While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Related Videos

ACT FAST! Congress Is POURING Into This Stock

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines